Cambridge, USA-based Korro Bio has entered a collaboration with Denmark’s Novo Nordisk to advance the discovery and ...

Novo Nordisk is under pressure over US drug prices as CEO Lars Fruergaard Jørgensen prepares to testify before the Senate ...

Marcus Remmers, a partner of the Planetary Health Investments team of Novo Holdings, the controlling shareholder of Novo ...

This news of Ozempic price cuts comes on the heels, or tablet, of Novo Nordisk developing a weight loss pill that mirrors the ...

Novo Nordisk exercises option to license Kallyope-identified ligand for therapeutic development including potential treatment for obesity ...

Senator Bernie Sanders (I-Vt.) once again ramped up pressure on weight loss drugmakers, announcing that he received ...

A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat diabetes says the drugmaker didn’t ...

The obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD ...

Issuer: CureVac / Key word (s): Conference/Study results CureVac’s CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress ...

Liraglutide has been found to safely reduce BMI in children aged 6 to under 12, offering a potential new treatment for pediatric obesity. The obesity medication liraglutide was found to be safe and ...

Obesity, a persistent metabolic state characterized by an excess accumulation of adipose tissue, has emerged as a global ...

the chair of the Health, Education, Labor, and Pensions Committee, wrote in an op-ed in USA Today that both drugmakers “must stop ripping off Americans with high drug prices.” In an interview in June, ...